Matches in Wikidata for { <http://www.wikidata.org/entity/Q37895402> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- Q37895402 description "article científic" @default.
- Q37895402 description "article scientifique" @default.
- Q37895402 description "articolo scientifico" @default.
- Q37895402 description "artigo científico" @default.
- Q37895402 description "artículu científicu espublizáu en xunu de 2011" @default.
- Q37895402 description "bilimsel makale" @default.
- Q37895402 description "scientific article published on 28 June 2011" @default.
- Q37895402 description "vedecký článok" @default.
- Q37895402 description "vetenskaplig artikel" @default.
- Q37895402 description "videnskabelig artikel" @default.
- Q37895402 description "vědecký článek" @default.
- Q37895402 description "wetenschappelijk artikel" @default.
- Q37895402 description "wissenschaftlicher Artikel" @default.
- Q37895402 description "наукова стаття, опублікована в червні 2011" @default.
- Q37895402 description "научни чланак" @default.
- Q37895402 description "مقالة علمية نشرت في 28 يونيو 2011" @default.
- Q37895402 name "Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable" @default.
- Q37895402 name "Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable" @default.
- Q37895402 type Item @default.
- Q37895402 label "Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable" @default.
- Q37895402 label "Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable" @default.
- Q37895402 prefLabel "Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable" @default.
- Q37895402 prefLabel "Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable" @default.
- Q37895402 P1433 Q37895402-38488747-A861-4A67-8A1B-FAFD097465FA @default.
- Q37895402 P1476 Q37895402-F9E70B2B-1645-47D6-BDD7-5D70FEB8C39B @default.
- Q37895402 P2093 Q37895402-102B7E8E-A14E-44FB-AD2E-8936611CB157 @default.
- Q37895402 P2093 Q37895402-1B7BE09E-90B9-469E-B929-B3B3A19ACAC0 @default.
- Q37895402 P2093 Q37895402-252F0170-0D2C-4FB6-BA00-94BF6230B0F5 @default.
- Q37895402 P2093 Q37895402-597C06D8-596C-4C38-959E-9045ED33AB11 @default.
- Q37895402 P2093 Q37895402-6473FB2B-3778-4C3D-A168-1D35D06CA4CE @default.
- Q37895402 P2093 Q37895402-AED722CF-D092-4A11-ABAD-9EAB45556FAA @default.
- Q37895402 P2093 Q37895402-D371C478-BF90-4034-B544-713A15AB1D0B @default.
- Q37895402 P2093 Q37895402-EB7D59A7-5869-4E10-84C0-73842CCF19BA @default.
- Q37895402 P2093 Q37895402-FE55A792-F32E-469B-BDA1-7907200243A3 @default.
- Q37895402 P304 Q37895402-840047FC-0855-4709-8BA2-1D21450B4833 @default.
- Q37895402 P31 Q37895402-CA40DE51-12FA-419E-9863-907F08E317E9 @default.
- Q37895402 P356 Q37895402-7F50BC34-9659-4D34-8CAD-64EB093AB39D @default.
- Q37895402 P407 Q37895402-013D90F7-DFE8-42A1-AF2C-0AB30FDCE667 @default.
- Q37895402 P433 Q37895402-9C829AD4-B567-4BB6-B107-C54DF1A31E6E @default.
- Q37895402 P478 Q37895402-AD7C19ED-C8DB-4404-8826-8C7AA5201DE4 @default.
- Q37895402 P50 Q37895402-6A6ECAA4-42C2-4A5C-ACEA-06FFCF706320 @default.
- Q37895402 P50 Q37895402-9D638363-D1A0-4C6A-921A-AF2C32769CD1 @default.
- Q37895402 P50 Q37895402-A8BD8617-130F-416B-AF7C-4AB3080734A0 @default.
- Q37895402 P50 Q37895402-AFA2BFF8-72C8-4AC3-BAAE-8F69485D9D4F @default.
- Q37895402 P50 Q37895402-E59DF8B2-2C20-4DC6-A056-DA48E4A10041 @default.
- Q37895402 P577 Q37895402-F9CAD442-3A5D-4F2B-AE7A-0B27EF3C8642 @default.
- Q37895402 P5875 Q37895402-3AFA35AB-236C-4C83-9862-8884CD51BE9E @default.
- Q37895402 P698 Q37895402-9881D3CB-71D6-41CB-B6D9-E76EB4D28455 @default.
- Q37895402 P921 Q37895402-3E314ABE-254B-4CBD-AAFA-38A169767EFD @default.
- Q37895402 P921 Q37895402-9D1F2711-E95E-4D1D-96B0-D91BF8D021A9 @default.
- Q37895402 P356 BJO.2011.204701 @default.
- Q37895402 P698 21712359 @default.
- Q37895402 P1433 Q13443571 @default.
- Q37895402 P1476 "Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable" @default.
- Q37895402 P2093 "Barry T Rouse" @default.
- Q37895402 P2093 "Daniel Meller" @default.
- Q37895402 P2093 "Francis W Price" @default.
- Q37895402 P2093 "Harminder Dua" @default.
- Q37895402 P2093 "Joseph Colin" @default.
- Q37895402 P2093 "Lies Remeijer" @default.
- Q37895402 P2093 "Manuel Diaz-Llopis" @default.
- Q37895402 P2093 "Patricia Udaondo" @default.
- Q37895402 P2093 "Salvador Garcia-Delpech" @default.
- Q37895402 P304 "3-9" @default.
- Q37895402 P31 Q13442814 @default.
- Q37895402 P356 "10.1136/BJO.2011.204701" @default.
- Q37895402 P407 Q1860 @default.
- Q37895402 P433 "1" @default.
- Q37895402 P478 "96" @default.
- Q37895402 P50 Q15280969 @default.
- Q37895402 P50 Q16206939 @default.
- Q37895402 P50 Q21140764 @default.
- Q37895402 P50 Q42876979 @default.
- Q37895402 P50 Q64866716 @default.
- Q37895402 P577 "2011-06-28T00:00:00Z" @default.
- Q37895402 P5875 "51451258" @default.
- Q37895402 P698 "21712359" @default.
- Q37895402 P921 Q1281049 @default.
- Q37895402 P921 Q574834 @default.